Literature DB >> 34775540

Pre-pectoral breast reconstruction: early and long-term safety evaluation of 146 unselected cases of the early pre-pectoral era of a single-institution, including cases with previous breast irradiation and post-mastectomy radiation therapy.

Marco Bernini1, Icro Meattini2,3, Calogero Saieva4, Carlotta Becherini2, Viola Salvestrini2, Luca Visani2, Giulia Stocchi2, Chiara Bellini2, Victoria Lorenzetti2, Silvia Sordi5, Jacopo Nori6, Diego De Benedetto6, Isacco Desideri2,3, Simonetta Bianchi7, Lorenzo Livi2,3, Lorenzo Orzalesi5.   

Abstract

We re-evaluated acute and early-late toxicity-related factors among pre-pectoral immediate tissue expander/implant (TE/I) breast reconstruction (BR) unselected, first-era, cases, including previous breast radiation treatment and post-mastectomy radiation therapy (PMRT). A retrospective analysis of 146 (117 therapeutic and 29 prophylactic) pre-pectoral reconstructions, between 2012 and 2016, considered patient-related (age, body mass index [BMI], smoke-history, comorbidity, BRCA mutation), and treatment-related characteristics (previous irradiation, axillary surgery, PMRT, pre- and postoperative chemotherapy, endocrine therapy, and target-therapy). Safety was evaluated as acute and early-late complications, and TE/I failures. At multivariate analysis of the 146 cases (117 patients submitted to BR) a significant factor related to acute toxicity was: BMI ≥ 25 (31.3% [≥ 25] vs 8.8% [< 25]; OR 4.44, 95% CI 1.56-12.6; p = 0.003), while previous breast surgery on ipsilateral side presented a borderline significance (31.6% [previous surgery] vs 7.4% [no previous surgery]; OR 3.74, 95% CI 0.97-14.40; p = 0.055). Factors significantly related to TE/I failure were: current or previous smoking exposition (13.8% [smokers] vs 2.6% [non-smokers]; OR 7.32, 95% CI 1.37-39.08; p = 0.02) and preoperative chemotherapy (18.8% [yes] vs 3.5% [no]; OR 8.16, 95% CI 1.29-51.63; p = 0.026). At 4-year median follow-up, 3 deaths, 5 locoregional recurrences, and 14 distant metastases occurred. Immediate pre-pectoral BR is safe and effective, with low rates of acute and early-late complications. BMI and previous breast surgery were related to higher complications but not failure; smoking and preoperative chemotherapy were related to TE/I explant. Previous RT and PMRT were related neither to early-late toxicity nor failure.
© 2021. The Author(s), under exclusive licence to The Japanese Breast Cancer Society.

Entities:  

Keywords:  Implant based breast reconstruction; Post-mastectomy radiation therapy; Pre-pectoral breast reconstruction

Mesh:

Year:  2021        PMID: 34775540     DOI: 10.1007/s12282-021-01314-0

Source DB:  PubMed          Journal:  Breast Cancer        ISSN: 1340-6868            Impact factor:   4.239


  39 in total

1.  Comparison of subcutaneous versus submuscular expander placement in the first stage of immediate breast reconstruction.

Authors:  Lin Zhu; Anita T Mohan; Jad M Abdelsattar; Zhen Wang; Aparna Vijayasekaran; Soyun M Hwang; Nho V Tran; Michel Saint-Cyr
Journal:  J Plast Reconstr Aesthet Surg       Date:  2016-01-20       Impact factor: 2.740

2.  Selective use of serial expansion in breast reconstruction.

Authors:  L C Argenta; M W Marks; W C Grabb
Journal:  Ann Plast Surg       Date:  1983-09       Impact factor: 1.539

3.  Breast reconstruction after mastectomy using the temporary expander.

Authors:  C Radovan
Journal:  Plast Reconstr Surg       Date:  1982-02       Impact factor: 4.730

4.  Prepectoral implant placement and complete coverage with porcine acellular dermal matrix: a new technique for direct-to-implant breast reconstruction after nipple-sparing mastectomy.

Authors:  Roland Reitsamer; Florentia Peintinger
Journal:  J Plast Reconstr Aesthet Surg       Date:  2014-10-16       Impact factor: 2.740

5.  Prepectoral Implant-Based Breast Reconstruction: Rationale, Indications, and Preliminary Results.

Authors:  Steven Sigalove; G Patrick Maxwell; Noemi M Sigalove; Toni L Storm-Dickerson; Nicole Pope; Jami Rice; Allen Gabriel
Journal:  Plast Reconstr Surg       Date:  2017-02       Impact factor: 4.730

Review 6.  Breast reconstruction following nipple-sparing mastectomy: a systematic review of the literature with pooled analysis.

Authors:  Matthew Endara; Duan Chen; Kapil Verma; Maurice Y Nahabedian; Scott L Spear
Journal:  Plast Reconstr Surg       Date:  2013-11       Impact factor: 4.730

7.  TiLoop® Bra mesh used for immediate breast reconstruction: comparison of retropectoral and subcutaneous implant placement in a prospective single-institution series.

Authors:  Donato Casella; Marco Bernini; Lapo Bencini; Jenny Roselli; Maria Teresa Lacaria; Jacopo Martellucci; Roberto Banfi; Claudio Calabrese; Lorenzo Orzalesi
Journal:  Eur J Plast Surg       Date:  2014-08-03

8.  Subcutaneous Tissue Expander Placement with Synthetic Titanium-Coated Mesh in Breast Reconstruction: Long-term Results.

Authors:  Donato Casella; Claudio Calabrese; Simonetta Bianchi; Icro Meattini; Marco Bernini
Journal:  Plast Reconstr Surg Glob Open       Date:  2016-01-07

9.  Subcutaneous Direct-to-Implant Breast Reconstruction: Surgical, Functional, and Aesthetic Results after Long-Term Follow-Up.

Authors:  Marco Bernini; Claudio Calabrese; Lorenzo Cecconi; Caterina Santi; Ulpjana Gjondedaj; Jenny Roselli; Jacopo Nori; Alfonso Fausto; Lorenzo Orzalesi; Donato Casella
Journal:  Plast Reconstr Surg Glob Open       Date:  2016-01-07

10.  Comparative Study of Prepectoral and Subpectoral Expander-Based Breast Reconstruction and Clavien IIIb Score Outcomes.

Authors:  Lynne N Bettinger; Linda M Waters; Stephen W Reese; Susan E Kutner; Daniel I Jacobs
Journal:  Plast Reconstr Surg Glob Open       Date:  2017-07-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.